Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (51-60 of 408) with videos related to

Pageof 41
Sort By:
The American Journal of Clinical Nutrition|August 8, 2014
The threshold shift paradigm of obesity: evidence from surgically induced weight lossEle Ferrannini, Michael Rosenbaum, Rudolph L Leibel
Journal of Hypertension|June 21, 2003
Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertensionMichaela Kozàkovà, Carmela Morizzo, Ele Ferrannini, et al.
Diabetes|January 30, 2002
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiationAndrea Mari, Andrea Tura, Amalia Gastaldelli, et al.
Diabetes Care|August 27, 2005
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesRichard Kahn, John Buse, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|December 15, 2021
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effectsSoo Lim, Minji Sohn, Yujin Shin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Coronary atherosclerosis and alcohol consumption: angiographic and mortality dataRomana Femia, Andrea Natali, Antonio L'Abbate, et al.
Cardiovascular Diabetology|September 29, 2021
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidenceAndrea Natali, Lorenzo Nesti, Domenico Tricò, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 13, 2007
LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanineSimona Baldi, Silvia Frascerra, Ele Ferrannini, et al.
Lancet (London, England)|December 6, 2005
The metabolic syndromeRichard Kahn, John Buse, Ele Ferrannini, et al.
Current Pharmaceutical Design|November 12, 2015
Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?Linda Landini, Miikka-Juhani Honka, Ele Ferrannini, et al.
Pageof 41

Showing results (51-60 of 408) with videos related to

Sort By:
Pageof 41
The American Journal of Clinical Nutrition|August 8, 2014
The threshold shift paradigm of obesity: evidence from surgically induced weight lossEle Ferrannini, Michael Rosenbaum, Rudolph L Leibel
Journal of Hypertension|June 21, 2003
Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertensionMichaela Kozàkovà, Carmela Morizzo, Ele Ferrannini, et al.
Diabetes|January 30, 2002
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiationAndrea Mari, Andrea Tura, Amalia Gastaldelli, et al.
Diabetes Care|August 27, 2005
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesRichard Kahn, John Buse, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|December 15, 2021
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effectsSoo Lim, Minji Sohn, Yujin Shin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Coronary atherosclerosis and alcohol consumption: angiographic and mortality dataRomana Femia, Andrea Natali, Antonio L'Abbate, et al.
Cardiovascular Diabetology|September 29, 2021
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidenceAndrea Natali, Lorenzo Nesti, Domenico Tricò, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 13, 2007
LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanineSimona Baldi, Silvia Frascerra, Ele Ferrannini, et al.
Lancet (London, England)|December 6, 2005
The metabolic syndromeRichard Kahn, John Buse, Ele Ferrannini, et al.
Current Pharmaceutical Design|November 12, 2015
Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?Linda Landini, Miikka-Juhani Honka, Ele Ferrannini, et al.
Pageof 41